JOINT FILING AGREEMENT PURSUANT TO RULE 13D-1(K)(1)
Exhibit 99.1
PURSUANT TO RULE 13D-1(K)(1)
The undersigned acknowledge and agree that the Statement on Schedule 13D filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the American Depositary Shares, each representing two common shares, par value NT$10.00 per share, of Taiwan Liposome Company, Ltd., is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D shall be filed on behalf of each of the undersigned that is named as a reporting person in such filing without the necessity of filing an additional joint filing agreement. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that it knows or has reason to believe that such information is inaccurate. This joint filing agreement may be executed in any number of counterparts and all of such counterparts taken together shall constitute one and the same instrument.
Dated: July 15, 2021
Xxxxx-Xxx Xxx
/s/ Xxxxx-Xxx Xxx
Xxxxx Xxx
/s/ Xxxxx Xxx
Chenghsien Lin
/s/ Chenghsien Lin
Tienhuo Chen
/s/ Tienhuo Chen
Chinpen Lin
/s/ Chinpen Lin
Taiping Wu
/s/ Taiping Wu
Xxxxxx Xxx
/s/ Xxxxxx Xxx
Xxxxxx Xxx
/s/ Xxxxxx Xxx
Xxxxxx Xxx
/s/ Xxxxxx Xxx
Keelung Hong
/s/ Keelung Hong
Xxxxxx Xxxx
/s/ Xxxxxx Xxxx
Topmunnity Therapeutics Taiwan Limited
By:/s/ Xxx Xxxxx
Name:Xxx Xxxxx
Title:Director
Champions Management Co., Ltd.
By:/s/ Xxx Xxxxx
Name:Xxx Xxxxx
Title:Director
Hongtai Investment Co., Ltd.
By:/s/ Xxxxxxx Xxxx
Name:Xxxxxxx Xxxx
Title:Director
